Arruñada Benito
Department of Economics and Business, Universitat Pompeu Fabra, Barcelona, Spain.
Health Econ. 2004 Apr;13(4):329-44. doi: 10.1002/hec.827.
Using econometric evidence, this article confirms that distribution of medicines online is split into two market segments of very diverse quality, and identifies the factors that drive quality and quality assurance in this activity. Unlike fraudulent, 'rogue,' websites, which offer scant guarantees and usually sell just a few medicines without prescription, online pharmacies offering insurance coverage and linked to conventional pharmacies typically sell a whole range of drugs, require third-party medical prescriptions and provide abundant information to patients. It is shown that, where online pharmacies are allowed to act legally, market forces enhance quality, as private insurers require professional standards, and specialized third parties make a business of certifying them. Furthermore, older online pharmacies and those running conventional operations offer higher quality, probably because of reputational investments. Overall, this evidence supports licensing online pharmacies, especially considering that prohibiting them is ineffective against fraudulent sites.
本文利用计量经济学证据证实,在线药品分销分为质量差异很大的两个市场细分领域,并确定了推动这一活动中质量和质量保证的因素。与那些几乎没有保障措施、通常无处方销售少数几种药品的欺诈性“流氓”网站不同,提供保险覆盖且与传统药店相关联的在线药店通常销售全系列药品,要求第三方医疗处方,并向患者提供丰富信息。研究表明,在允许在线药店合法经营的地方,市场力量会提高质量,因为私人保险公司要求专业标准,而专业第三方以对其进行认证为业。此外,运营时间较长的在线药店和那些经营传统业务的药店质量更高,这可能是由于声誉投资。总体而言,这一证据支持对在线药店进行许可,特别是考虑到禁止它们对欺诈性网站无效。